SCHEMBL7146760

SCHEMBL7146760

CC(C)(C)OC(=O)COc1cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc1C#Cc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
POLB P06746 4/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 2/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39
MEN1 O00255 1/20 0.38
F2 P00734 1/20 0.38
KMT2A Q03164 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TDP1 Q9NUW8 3/20 0.37
GAA P10253 1/20 0.36
RECQL P46063 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143195 0.88 FFAR1 (0.39) ALDH1A1HTTSMN1; SMN2POLBNPC1
SCHEMBL7138020 0.88 ALDH1A1 (0.39) ALDH1A1HTTSMN1; SMN2POLBNPC1
SCHEMBL7138026 0.88 MAPT (0.41) ALDH1A1HTTSMN1; SMN2NPC1RAB9A
SCHEMBL7141733 0.86 L3MBTL1 (0.40) ALDH1A1HTTSMN1; SMN2POLBNPC1
SCHEMBL7143531 0.86 ALDH1A1 (0.41) ALDH1A1HTTNPC1RAB9AMAPT
SCHEMBL6167226 0.85 NPC1 (0.38) ALDH1A1HTTSMN1; SMN2POLBNPC1
SCHEMBL7141263 0.85 PTGDR2 (0.41) POLBMAPTPTGDR2
SCHEMBL7142233 0.84 PDGFRB (0.37) ALDH1A1HTTSMN1; SMN2POLBNPC1
SCHEMBL7140140 0.83 MAPT (0.43) ALDH1A1HTTSMN1; SMN2NPC1RAB9A
SCHEMBL7142921 0.82 NPC1 (0.39) ALDH1A1HTTSMN1; SMN2POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed